121 related articles for article (PubMed ID: 28393715)
21. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
[TBL] [Abstract][Full Text] [Related]
22. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study.
Skinner KE; Fernandes AW; Walker MS; Pavilack M; VanderWalde A
J Med Econ; 2018 Feb; 21(2):192-200. PubMed ID: 29041833
[TBL] [Abstract][Full Text] [Related]
23. Radiological, Bronchoscopic and Histopathologic Characteristics of Patients with Primary Lung Cancer in Turkey (2006-2009).
Sahin F; Yildiz P
Asian Pac J Cancer Prev; 2011; 12(8):1947-52. PubMed ID: 22292630
[TBL] [Abstract][Full Text] [Related]
24. Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.
Cipriano LE; Romanus D; Earle CC; Neville BA; Halpern EF; Gazelle GS; McMahon PM
Value Health; 2011 Jan; 14(1):41-52. PubMed ID: 21211485
[TBL] [Abstract][Full Text] [Related]
25. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study.
Lei Y; Feng H; Qiang H; Shang Z; Chang Q; Qian J; Zhang Y; Zhong R; Fan X; Chu T
Lung Cancer; 2020 Aug; 146():244-251. PubMed ID: 32592985
[TBL] [Abstract][Full Text] [Related]
27. [Expression of EGFR, survivn and hnRNPA2/B1 in bronchial brushing cytology specimens and their significance in diagnosis of lung cancer].
Lu SS; Pan QJ; Zhao LL; Guo HQ; Zhang ZH; Cao J
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):621-5. PubMed ID: 22325225
[TBL] [Abstract][Full Text] [Related]
28. Treatment cost of non-small cell lung cancer in three European countries: comparisons across France, Germany, and England using administrative databases.
McGuire A; Martin M; Lenz C; Sollano JA
J Med Econ; 2015; 18(7):525-32. PubMed ID: 25802950
[TBL] [Abstract][Full Text] [Related]
29. Delays during the diagnostic evaluation and treatment of lung cancer.
Chandra S; Mohan A; Guleria R; Singh V; Yadav P
Asian Pac J Cancer Prev; 2009; 10(3):453-6. PubMed ID: 19640190
[TBL] [Abstract][Full Text] [Related]
30. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas.
Travis WD
Mod Pathol; 2012 Jan; 25 Suppl 1():S18-30. PubMed ID: 22214967
[TBL] [Abstract][Full Text] [Related]
31. Relationship between primary lesion metabolic parameters and clinical stage in lung cancer.
Sahiner I; Atasever T; Akdemir UO; Ozturk C; Memis L
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):357-63. PubMed ID: 23747221
[TBL] [Abstract][Full Text] [Related]
32. Guidelines for multimodality radiological staging of lung cancer.
Loutfi S; Khankan A; Al Ghanim S
J Infect Public Health; 2012 Dec; 5 Suppl 1():S14-21. PubMed ID: 23244181
[TBL] [Abstract][Full Text] [Related]
33. Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer.
Billingham LJ; Bathers S; Burton A; Bryan S; Cullen MH
Lung Cancer; 2002 Aug; 37(2):219-25. PubMed ID: 12140146
[TBL] [Abstract][Full Text] [Related]
34. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
Kwan SW; Mortell KE; Hippe DS; Brunner MC
J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
[TBL] [Abstract][Full Text] [Related]
35. Trends in Stage I Lung Cancer.
Singareddy A; Flanagan ME; Samson PP; Waqar SN; Devarakonda S; Ward JP; Herzog BH; Rohatgi A; Robinson CG; Gao F; Govindan R; Puri V; Morgensztern D
Clin Lung Cancer; 2023 Mar; 24(2):114-119. PubMed ID: 36504141
[TBL] [Abstract][Full Text] [Related]
36. [The impacts of the multidisciplinary team model on the length of stay and hospital expenses of patients with lung cancer].
Zou J; Xu X; Wang D; Xu J; Gu W
Zhonghua Jie He He Hu Xi Za Zhi; 2015 May; 38(5):370-4. PubMed ID: 26463490
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601).
Decroisette C; Monnet I; Berard H; Quere G; Le Caer H; Bota S; Audigier-Valette C; Geriniere L; Vernejoux JM; Chouaid C;
J Thorac Oncol; 2011 Mar; 6(3):576-82. PubMed ID: 21270669
[TBL] [Abstract][Full Text] [Related]
38. Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea.
Park JY; Lee YJ; Kim T; Lee CY; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Jang SH
BMC Cancer; 2020 Oct; 20(1):1040. PubMed ID: 33121456
[TBL] [Abstract][Full Text] [Related]
39. Differentiating Small-Cell Lung Cancer From Non-Small-Cell Lung Cancer Brain Metastases Based on MRI Using Efficientnet and Transfer Learning Approach.
Grossman R; Haim O; Abramov S; Shofty B; Artzi M
Technol Cancer Res Treat; 2021; 20():15330338211004919. PubMed ID: 34030542
[TBL] [Abstract][Full Text] [Related]
40. Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States.
Zhang X; Beachler DC; Masters E; Liu F; Yang M; Dinh J; Jamal-Allial A; Kolitsopoulos F; Lamy FX
J Manag Care Spec Pharm; 2022 Feb; 28(2):255-265. PubMed ID: 34854733
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
